Skip to main content

January 2020

 

Clinical courses

 

Clinical research courses

Sanofi looking for Manager

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.  With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Post : Manager

Risk of cardiac events

United Kingdom. The MHRA has announced that cases of cardiac arrest, cardiac failure and myocardial infarction were reported in patients taking carfilzomib (Kyprolis®).

Risk of QT interval prolongation

New Zealand. Medsafe has announced that patients taking natural health products containing Artemisia annua may be at risk of QT interval prolongation.

Bhubaneswar-based Institute of Life Sciences, an autonomous institution under the Department of Biotechnology, has signed a collaborative agreement with All India Institute of Medical Sciences, Bhubaneswar for undertaking advanced research in the area of human health & welfare. The pact aims to strengthen partnershipbetween the two institutions in research,education and outreach.

Pharmacovigilance Programme of India (PvPI) urges healthcare professionals to take require measures and do not prescribe Nimesulide for children under 12 years of age. PvPI urges to spread awareness among healthcare professionals to take all necessary precautions in order to avoid such mishappenings and to promote rational use of medicines.

Recruitment for Pharmacists (15 posts) under GOVERNMENT OF NCT - DSSSB

The Directorate of Family Welfare was established in the year 1976 as a part of the Directorate of Health Services subsequently around 1992-93, the department of Family Welfare was separately administratively from Director of Health Services .The need to reduce the IMR, MMR & TFR, it became imperative to have an independent organizational set up for the Directorate of Family Welfare on the pattern of similar directorates countrywide. The various activities include planning, implementing, supervising, collaborating, monitoring and evaluating various aspects of RMNCH + A Program, a flagship program under NRHM has six components:- Reproductive, Maternal, Neonatal, Child & Adolescent Health.

Online Applications are invited for recruitment to the following posts under various Departments of Govt. of NCT of Delhi

Post : Pharmacist

Vacancy for Scientist, SRF at PGIMER | M.Pharm or M.Sc

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963.

Job for Junior Research Fellow at NIRRH

National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier research institute of the Indian Council of Medical Research (ICMR). It is situated in the vicinity of a number of hospitals and research institutes in central Mumbai. Since its inception in 1970, it has been making vigorous efforts to improve the reproductive health of people through research, education and health care services.

Post : Junior Research Fellow

Applications are invited for RFA on Drug Development at BIRAC

India is a leader in global generic pharmaceuticals manufacturing. However, many generics manufactured in India are at the end of their respective product life cycle, with limited new research and development taking place on new drugs. Furthermore, our country has a high burden of both communicable and non-communicable diseases and is vulnerable to epidemics. In order to keep pace with global innovation and to improve health outcomes, there is a need to foster R&D for new and cost-effective therapies. With the aim to take India at global map in terms of R&D innovations in the area of drug development in our country, the Department has initiated a new program on “Drug Development” with a vision to develop indigenous and cost-effective new drugs against the following diseases.